208 related articles for article (PubMed ID: 36182039)
1. Losartan attenuates sepsis-induced cardiomyopathy by regulating macrophage polarization via TLR4-mediated NF-κB and MAPK signaling.
Chen XS; Wang SH; Liu CY; Gao YL; Meng XL; Wei W; Shou ST; Liu YC; Chai YF
Pharmacol Res; 2022 Nov; 185():106473. PubMed ID: 36182039
[TBL] [Abstract][Full Text] [Related]
2. Angiotensin-(1-7) ameliorates sepsis-induced cardiomyopathy by alleviating inflammatory response and mitochondrial damage through the NF-κB and MAPK pathways.
Chen XS; Cui JR; Meng XL; Wang SH; Wei W; Gao YL; Shou ST; Liu YC; Chai YF
J Transl Med; 2023 Jan; 21(1):2. PubMed ID: 36593471
[TBL] [Abstract][Full Text] [Related]
3. Rosuvastatin attenuates Ang II--mediated cardiomyocyte hypertrophy via inhibition of LOX-1.
Kang BY; Mehta JL
J Cardiovasc Pharmacol Ther; 2009 Dec; 14(4):283-91. PubMed ID: 19724024
[TBL] [Abstract][Full Text] [Related]
4. Elevated angiotensin II induces platelet apoptosis through promoting oxidative stress in an AT1R-dependent manner during sepsis.
Xu DF; Liu YJ; Mao YF; Wang Y; Xu CF; Zhu XY; Jiang L
J Cell Mol Med; 2021 Apr; 25(8):4124-4135. PubMed ID: 33624364
[TBL] [Abstract][Full Text] [Related]
5. Angiotensin II signaling via type 2 receptors in a human model of vascular hyporeactivity: implications for hypertension.
Calò LA; Schiavo S; Davis PA; Pagnin E; Mormino P; D'Angelo A; Pessina AC
J Hypertens; 2010 Jan; 28(1):111-8. PubMed ID: 19797979
[TBL] [Abstract][Full Text] [Related]
6. The role of monocyte chemotactic protein-induced protein 1 (MCPIP1) in angiotensin II-induced macrophage apoptosis and vulnerable plaque formation.
Shu S; Zhang Y; Li W; Wang L; Wu Y; Yuan Z; Zhou J
Biochem Biophys Res Commun; 2019 Jul; 515(2):378-385. PubMed ID: 31155290
[TBL] [Abstract][Full Text] [Related]
7. Angiotensin-converting enzyme 2/angiotensin-(1-7)/Mas axis protects against lung fibrosis by inhibiting the MAPK/NF-κB pathway.
Meng Y; Yu CH; Li W; Li T; Luo W; Huang S; Wu PS; Cai SX; Li X
Am J Respir Cell Mol Biol; 2014 Apr; 50(4):723-36. PubMed ID: 24168260
[TBL] [Abstract][Full Text] [Related]
8. Angiotensin II induces the expression of tissue factor and its mechanism in human monocytes.
He M; He X; Xie Q; Chen F; He S
Thromb Res; 2006; 117(5):579-90. PubMed ID: 15953627
[TBL] [Abstract][Full Text] [Related]
9. Losartan prevents sepsis-induced acute lung injury and decreases activation of nuclear factor kappaB and mitogen-activated protein kinases.
Shen L; Mo H; Cai L; Kong T; Zheng W; Ye J; Qi J; Xiao Z
Shock; 2009 May; 31(5):500-6. PubMed ID: 18827741
[TBL] [Abstract][Full Text] [Related]
10. Angiotensin II/angiotensin II type I receptor (AT1R) signaling promotes MCF-7 breast cancer cells survival via PI3-kinase/Akt pathway.
Zhao Y; Chen X; Cai L; Yang Y; Sui G; Fu S
J Cell Physiol; 2010 Oct; 225(1):168-73. PubMed ID: 20458733
[TBL] [Abstract][Full Text] [Related]
11. Angiotensin II receptor type 1 blockers suppress the cell proliferation effects of angiotensin II in breast cancer cells by inhibiting AT1R signaling.
Du N; Feng J; Hu LJ; Sun X; Sun HB; Zhao Y; Yang YP; Ren H
Oncol Rep; 2012 Jun; 27(6):1893-903. PubMed ID: 22426690
[TBL] [Abstract][Full Text] [Related]
12. Angiotensin II type 2 receptors contribute to vascular responses in spontaneously hypertensive rats treated with angiotensin II type 1 receptor antagonists.
Cosentino F; Savoia C; De Paolis P; Francia P; Russo A; Maffei A; Venturelli V; Schiavoni M; Lembo G; Volpe M
Am J Hypertens; 2005 Apr; 18(4 Pt 1):493-9. PubMed ID: 15831358
[TBL] [Abstract][Full Text] [Related]
13. Role of Angiotensin II type 1 receptor on renal NAD(P)H oxidase, oxidative stress and inflammation in nitric oxide inhibition induced-hypertension.
Rincón J; Correia D; Arcaya JL; Finol E; Fernández A; Pérez M; Yaguas K; Talavera E; Chávez M; Summer R; Romero F
Life Sci; 2015 Mar; 124():81-90. PubMed ID: 25623850
[TBL] [Abstract][Full Text] [Related]
14. Inhibition of NF-κB-induced inflammatory responses by angiotensin II antagonists in aged rat kidney.
Kim JM; Heo HS; Choi YJ; Ye BH; Mi Ha Y; Seo AY; Yu BP; Leeuwenburgh C; Chung HY; Carter CS
Exp Gerontol; 2011 Jul; 46(7):542-8. PubMed ID: 21377515
[TBL] [Abstract][Full Text] [Related]
15. AT1 receptor blockage impairs NF-κB activation mediated by thyroid hormone in cardiomyocytes.
Takano APC; Senger N; Munhoz CD; Barreto-Chaves MLM
Pflugers Arch; 2018 Mar; 470(3):549-558. PubMed ID: 29178049
[TBL] [Abstract][Full Text] [Related]
16. Curcumin reduces angiotensin II-mediated cardiomyocyte growth via LOX-1 inhibition.
Kang BY; Khan JA; Ryu S; Shekhar R; Seung KB; Mehta JL
J Cardiovasc Pharmacol; 2010 Apr; 55(4):417-24. PubMed ID: 20422739
[TBL] [Abstract][Full Text] [Related]
17. Angiotensin II promotes cardiac differentiation of embryonic stem cells via angiotensin type 1 receptor.
Wu L; Jia Z; Yan L; Wang W; Wang J; Zhang Y; Zhou C
Differentiation; 2013; 86(1-2):23-9. PubMed ID: 23933399
[TBL] [Abstract][Full Text] [Related]
18. The angiotensin receptor blocker, Losartan, inhibits mammary tumor development and progression to invasive carcinoma.
Coulson R; Liew SH; Connelly AA; Yee NS; Deb S; Kumar B; Vargas AC; O'Toole SA; Parslow AC; Poh A; Putoczki T; Morrow RJ; Alorro M; Lazarus KA; Yeap EFW; Walton KL; Harrison CA; Hannan NJ; George AJ; Clyne CD; Ernst M; Allen AM; Chand AL
Oncotarget; 2017 Mar; 8(12):18640-18656. PubMed ID: 28416734
[TBL] [Abstract][Full Text] [Related]
19. The angiotensin II receptor antagonist, losartan, enhances regulator of G protein signaling 2 mRNA expression in vascular smooth muscle cells of Wistar rats.
Wu Y; Nakagawa S; Takahashi H; Kawabata Y; Suzuki E; Uehara Y
Hypertens Res; 2016 May; 39(5):295-301. PubMed ID: 26763849
[TBL] [Abstract][Full Text] [Related]
20. Losartan attenuates ventilator-induced lung injury.
Yao S; Feng D; Wu Q; Li K; Wang L
J Surg Res; 2008 Mar; 145(1):25-32. PubMed ID: 17688881
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
